SNMMI is a global and collaborative scientific organization dedicated to both the practice and the science of nuclear medicine and molecular imaging and therapy around the world. SNMMI's worldwide membership totals more than 18,000, including physicians, scientists, technologists, chemists, radiopharmacists, students and industry representatives from 76 countries around the world.
SNMMI is a global and collaborative scientific organization dedicated to both the practice and the science of nuclear medicine and molecular imaging and therapy around the world. SNMMI's worldwide membership totals over 18,000, which includes physicians, scientists, technologists, chemists, radiopharmacists, students and industry representatives from more than 75 countries around the world. SNMMI's Journal of Nuclear Medicine (JNM), the premier international journal of nuclear medicine, reaches over 18,000 individuals each month. SNMMI's Annual Meeting is nuclear medicine's and molecular iamging's largest gathering each year, attracting over 4,000 professional attendees and another 2,500 industry representatives.
At the most recent Annual Meeting in June 2013 in Vancouver, BC, Canada, 38% of registered attendees were from countries other than the United States. Attendees represented over 69 countries. In addition, abstract submissions for SNMMI's Annual Meeting from outside the United States represent close to 65% of all submissions.
While SNMMI's headquarters office resides in Virginia, just outside of Washington, D.C., its perspective, programs, and growth are as international as its members. As of 2013, more than 11.8% of the Society's members reside in more than 75 countries other than the United States.
Search for an international nuclear medicine and molecular imaging organization near you.
SNMMI's educational programs and activities reflect the increasing importance and participation of its international members. Such common global nuclear medicine and molecular imaging and therapy issues as quality of care, educating referring physicians and patients, and exploring ways to better share developments in the practice of nuclear medicine and molecular imaging and therapy are but a few of the activities currently underway by Society staff, Committees, Councils, and our Centers of Excellence. This website seeks to constantly expand its offerings to the Society's international members, providing an ever-changing, updated array of global resources and news for nuclear medicine and molecular imaging and therapy professionals literally anywhere on the globe.
SNMMI continues to stay actively involved in several jointly sponsored educational programs and educational outreach activities with regional nuclear medicine and molecular imaging and therapy organizations around the world; both in their home countries, and during SNMMI's Annual Meeting. These joint sponsored programs include not only the sharing of speakers and renown experts on all facets of nuclear medicine and molecular imaging, collaboration on the development of enduring educational materials, and programmatic/administrative support, but also include translation of materials and website development.
Each year, the SNMMI collaborates with international organizations in an effort to continue the exchange of ideas, education and knowledge. Intiatives include:
Nuclear Medicine Global Initiative
3rd Sino-American Conference
Chinese/U.S. Resident Exchange Program
IAEA CT Case Webinar Series
EANM Collaborative Guidelines
SNMMI 2015 Annual Meeting | 6-10 June 2015 | Baltimore, Maryland, USA
The SNMMI Annual Meeting has been recognized by thousands of professional attendees from across the globe as the premier educational and networking event in molecular imaging and nuclear medicine. The 2015 Annual Meeting will continue to build on past successes offering: the latest educational content; virtual learning opportunities both during the meeting and post-conference; networking events; and an exhibit hall packed with the latest technology.
SNMMI 2015 Mid-Winter Meeting | 22-25 January 2015 | San Antonio, Texas, USA
San Antonio, Texas. From the historic legacy of the Alamo to the modern vibrancy of its graceful River Walk, stellar arts reputation, and increasingly acclaimed culinary and retail scene, San Antonio has come to define both classic and contemporary Texas.
SNMMI, with its historic legacy and modern relevance as a leading voice of the profession, has developed a program of first-class offerings highlighting the current and emerging technical, preclinical, and clinical applications of nuclear medicine and molecular imaging.
AACR-SNMMI Joint Conference on State of the Art: Molecular Imaging in Cancer Biology and Therapy | 11-14 February 2015 | San Diego, California, USA
This joint meeting between the AACR and the Society of Nuclear Medicine and Molecular Imaging will bring together imaging scientists with biologists in basic, translational, and clinical research to explore how new findings in molecular imaging can improve cancer diagnostics, treatment, and patient outcomes.
3rd Theranostics World Congress (3TWC) on Ga-68 and PRRT | 12-14 March 2015 | Baltimore, Maryland, USA
This conference will provide updates on recent developments in the exciting field of Theranostics for NETs, prostate, and beyond. A team of experts from around the world will discuss their research and experience in this exciting field.
SNMMI offers a Full International Membership category for inernational colleagues. Learn more on how to become an SNMMI Full Member (international).
Available to physicians, scientists or pharmacists possessing an advanced degree who have presented credentials indicating their professional activity, either, medical, paramedical, investigational or educational in the scientific or clinical disciplines of molecular imaging or nuclear medicine. This includes the diagnostic, therapeutic or investigational use of radionuclides or other molecular imaging technologies.
Annual dues: $460
Includes subscription to The Journal of Nuclear Medicine.
Includes voting rights and can be elected an Officer of the SNMMI.
As part of its continuing commitment to growing the practice of nuclear medicine and molecular imaging and therapy worldwide, SNMMI leadership works diligently to develop strategic alliances with key regional nuclear medicine organizations to assist these groups in expanding the scope and quality of nuclear medicine outside the United States. These strategic alliances stretch across the globe. reaching every continent where SNMMI's members reside and practice.
SNMMI Partners and Alliances Include:
For more information on SNMMI's international activities and programs, please contact:
Nikki Wenzel-Lamb, MBA Director of Leadership Direct: 703-652-6766 Fax: 703-708-9020 Email: email@example.com
PET/CT with Ga-68 DOTATATE has been found to change treatment plans in a majority of patients receiving initial evaluation and subsequent staging of neuroendocrine tumors (NETs).
(MI: Making a Difference)
The aim of this prospective study was to assess the diagnostic performance of whole-body nonenhanced PET/MR and nonenhanced PET/CT in 106 patients with a variety of cancers.
(SNMMI in the News)
Following Senator Mary Landrieu’s (D-LA) defeat to Rep. Bill Cassidy (R-LA) on December 6, Republicans now hold a 54-46 majority in the Senate. Republicans also retained control of the House of Representatives with a 244-188 majority.
(Government Relations News)
Quantitative PET using agents like FDG could predict the outcome of chemotherapy for patients with particularly tricky cases of advanced breast cancer, according to a study published Dec. 4 in the Journal of Nuclear Medicine .
(MI: Making a Difference)
SNMMI offers opportunities to submit clinical and scientific abstracts to be considered for presentation at upcoming SNMMI conferences and meetings:
SNMMI 2015 Annual Meeting
June 6-10, 2015 in Baltimore, MD, USA
Abstract Submission Deadline: January 12, 2015
Learn more about journals published by or sponsored by the Society of Nuclear Medicine and Molecular Imaging.
Tools, supported by evidence, to harmonize the practice of nuclear medicine using a progressive and safe approach.